215600 — SillaJen Share News
0.000.00%
Last trade - 00:00- KR₩305bn
- KR₩235bn
- KR₩9bn
S.Korean stocks gain on improved sentiment in pharma sector
S.Korea stocks slump over 2% on escalating tension with Japan, trade worries
S.Korea's pharma firms plunge after SillaJen's halted clinical tests
Brief: Regeneron and Sillajen report immuno-oncology clinical study agreement
Brief: SillaJen and Transgene enroll first European patient in Phase 3 trial for Pexa-Vec
Brief: SillaJen lowers conversion price of 27th 28th 29th series convertible bonds to 11,694 won/share